Proactiveinvestors Australia Imugene Ltd https://www.proactiveinvestors.com.au Proactiveinvestors Australia Imugene Ltd RSS feed en Thu, 17 Oct 2019 07:13:24 +1100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Imugene presents HER2 immuno-oncology vaccines success at ESMO ahead of 2020 studies https://www.proactiveinvestors.com.au/companies/news/903841/imugene-presents-her2-immuno-oncology-vaccines-success-at-esmo-ahead-of-2020-studies-903841.html Tue, 01 Oct 2019 05:06:00 +1000 https://www.proactiveinvestors.com.au/companies/news/903841/imugene-presents-her2-immuno-oncology-vaccines-success-at-esmo-ahead-of-2020-studies-903841.html Imugene to acquire exclusive licence for potentially transformational oncolytic virus technology https://www.proactiveinvestors.com.au/companies/news/223858/imugene-to-acquire-exclusive-licence-for-potentially-transformational-oncolytic-virus-technology-223858.html Mon, 15 Jul 2019 01:46:00 +1000 https://www.proactiveinvestors.com.au/companies/news/223858/imugene-to-acquire-exclusive-licence-for-potentially-transformational-oncolytic-virus-technology-223858.html Imugene reveals new clinical data for HER-Vaxx vaccine showing cancer-fighting response https://www.proactiveinvestors.com.au/companies/news/223460/imugene-reveals-new-clinical-data-for-her-vaxx-vaccine-showing-cancer-fighting-response-223460.html Mon, 08 Jul 2019 02:39:00 +1000 https://www.proactiveinvestors.com.au/companies/news/223460/imugene-reveals-new-clinical-data-for-her-vaxx-vaccine-showing-cancer-fighting-response-223460.html Imugene Limited releases new clinical data for HER-Vaxx cancer vaccine study https://www.proactiveinvestors.com.au/companies/news/314003/imugene-limited-releases-new-clinical-data-for-her-vaxx-cancer-vaccine-study-14003.html Mon, 08 Jul 2019 02:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/314003/imugene-limited-releases-new-clinical-data-for-her-vaxx-cancer-vaccine-study-14003.html Imugene presents new HER-Vaxx cancer vaccine results https://www.proactiveinvestors.com.au/companies/news/221426/imugene-presents-new-her-vaxx-cancer-vaccine-results-221426.html Tue, 04 Jun 2019 00:57:00 +1000 https://www.proactiveinvestors.com.au/companies/news/221426/imugene-presents-new-her-vaxx-cancer-vaccine-results-221426.html Imugene appoints venture capital executive to board https://www.proactiveinvestors.com.au/companies/news/220548/imugene-appoints-venture-capital-executive-to-board-220548.html Mon, 20 May 2019 01:46:00 +1000 https://www.proactiveinvestors.com.au/companies/news/220548/imugene-appoints-venture-capital-executive-to-board-220548.html Imugene to present new data from HER-Vaxx cancer vaccine phase 1b trial https://www.proactiveinvestors.com.au/companies/news/219213/imugene-to-present-new-data-from-her-vaxx-cancer-vaccine-phase-1b-trial-219213.html Mon, 29 Apr 2019 02:51:00 +1000 https://www.proactiveinvestors.com.au/companies/news/219213/imugene-to-present-new-data-from-her-vaxx-cancer-vaccine-phase-1b-trial-219213.html Imugene appoints global pharmaceutical executive to its board https://www.proactiveinvestors.com.au/companies/news/218913/imugene-appoints-global-pharmaceutical-executive-to-its-board-218913.html Tue, 23 Apr 2019 02:16:00 +1000 https://www.proactiveinvestors.com.au/companies/news/218913/imugene-appoints-global-pharmaceutical-executive-to-its-board-218913.html Imugene well-funded to progress clinical milestones https://www.proactiveinvestors.com.au/companies/news/218631/imugene-well-funded-to-progress-clinical-milestones-218631.html Tue, 16 Apr 2019 01:52:00 +1000 https://www.proactiveinvestors.com.au/companies/news/218631/imugene-well-funded-to-progress-clinical-milestones-218631.html Imugene presents positive new data validating its human cancer vaccine KEY-Vaxx https://www.proactiveinvestors.com.au/companies/news/217820/imugene-presents-positive-new-data-validating-its-human-cancer-vaccine-key-vaxx-217820.html Wed, 03 Apr 2019 04:40:00 +1100 https://www.proactiveinvestors.com.au/companies/news/217820/imugene-presents-positive-new-data-validating-its-human-cancer-vaccine-key-vaxx-217820.html Imugene reveals new data on cancer vaccine programs https://www.proactiveinvestors.com.au/companies/news/217702/imugene-reveals-new-data-on-cancer-vaccine-programs-217702.html Tue, 02 Apr 2019 01:27:00 +1100 https://www.proactiveinvestors.com.au/companies/news/217702/imugene-reveals-new-data-on-cancer-vaccine-programs-217702.html Imugene obtains FDA guidance for KEY-Vaxx immunotherapy clinical development plan https://www.proactiveinvestors.com.au/companies/news/312652/imugene-obtains-fda-guidance-for-key-vaxx-immunotherapy-clinical-development-plan-12652.html Wed, 20 Mar 2019 00:19:00 +1100 https://www.proactiveinvestors.com.au/companies/news/312652/imugene-obtains-fda-guidance-for-key-vaxx-immunotherapy-clinical-development-plan-12652.html Imugene gets development roadmap for cancer vaccine from FDA meeting https://www.proactiveinvestors.com.au/companies/news/216795/imugene-gets-development-roadmap-for-cancer-vaccine-from-fda-meeting-216795.html Wed, 20 Mar 2019 00:08:00 +1100 https://www.proactiveinvestors.com.au/companies/news/216795/imugene-gets-development-roadmap-for-cancer-vaccine-from-fda-meeting-216795.html Imugene doses first patient in phase-two study of cancer vaccine https://www.proactiveinvestors.com.au/companies/news/312615/imugene-doses-first-patient-in-phase-two-study-of-cancer-vaccine-12615.html Fri, 15 Mar 2019 05:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/312615/imugene-doses-first-patient-in-phase-two-study-of-cancer-vaccine-12615.html Imugene doses milestone first patient for cancer vaccine trial https://www.proactiveinvestors.com.au/companies/news/216427/imugene-doses-milestone-first-patient-for-cancer-vaccine-trial-216427.html Wed, 13 Mar 2019 23:38:00 +1100 https://www.proactiveinvestors.com.au/companies/news/216427/imugene-doses-milestone-first-patient-for-cancer-vaccine-trial-216427.html Imugene to make further cancer vaccine research presentations at AACR annual meeting https://www.proactiveinvestors.com.au/companies/news/215661/imugene-to-make-further-cancer-vaccine-research-presentations-at-aacr-annual-meeting-215661.html Mon, 04 Mar 2019 01:15:00 +1100 https://www.proactiveinvestors.com.au/companies/news/215661/imugene-to-make-further-cancer-vaccine-research-presentations-at-aacr-annual-meeting-215661.html Imugene presenting all three immuno-oncology programs at AACR Annual Meeting https://www.proactiveinvestors.com.au/companies/news/312423/imugene-presenting-all-three-immuno-oncology-programs-at-aacr-annual-meeting-12423.html Sun, 03 Mar 2019 23:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/312423/imugene-presenting-all-three-immuno-oncology-programs-at-aacr-annual-meeting-12423.html Imugene to present cancer vaccine research at AACR annual meeting https://www.proactiveinvestors.com.au/companies/news/215464/imugene-to-present-cancer-vaccine-research-at-aacr-annual-meeting-215464.html Thu, 28 Feb 2019 01:12:00 +1100 https://www.proactiveinvestors.com.au/companies/news/215464/imugene-to-present-cancer-vaccine-research-at-aacr-annual-meeting-215464.html Imugene will present lead candidate HER-Vaxx at AACR Annual Meeting https://www.proactiveinvestors.com.au/companies/news/312382/imugene-will-present-lead-candidate-her-vaxx-at-aacr-annual-meeting-12382.html Wed, 27 Feb 2019 22:37:00 +1100 https://www.proactiveinvestors.com.au/companies/news/312382/imugene-will-present-lead-candidate-her-vaxx-at-aacr-annual-meeting-12382.html Imugene has cancer vaccine trial data published in prestigious medical journal https://www.proactiveinvestors.com.au/companies/news/215268/imugene-has-cancer-vaccine-trial-data-published-in-prestigious-medical-journal-215268.html Tue, 26 Feb 2019 01:23:00 +1100 https://www.proactiveinvestors.com.au/companies/news/215268/imugene-has-cancer-vaccine-trial-data-published-in-prestigious-medical-journal-215268.html Imugene targets defender B-cells with cancer vaccines HER-Vaxx and B-Vaxx https://www.proactiveinvestors.com.au/companies/news/214505/imugene-targets-defender-b-cells-with-cancer-vaccines-her-vaxx-and-b-vaxx-214505.html Wed, 13 Feb 2019 03:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/214505/imugene-targets-defender-b-cells-with-cancer-vaccines-her-vaxx-and-b-vaxx-214505.html Imugene adds key members to its scientific advisory board to advance company forward https://www.proactiveinvestors.com.au/companies/news/311802/imugene-adds-key-members-to-its-scientific-advisory-board-to-advance-company-forward-11802.html Fri, 11 Jan 2019 15:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/311802/imugene-adds-key-members-to-its-scientific-advisory-board-to-advance-company-forward-11802.html Imugene begins manufacture of its innovative cancer vaccine for trials https://www.proactiveinvestors.com.au/companies/news/205478/imugene-begins-manufacture-of-its-innovative-cancer-vaccine-for-trials-205478.html Sun, 23 Sep 2018 22:07:00 +1000 https://www.proactiveinvestors.com.au/companies/news/205478/imugene-begins-manufacture-of-its-innovative-cancer-vaccine-for-trials-205478.html Imugene signs exclusive, world-wide licence for cancer vaccine https://www.proactiveinvestors.com.au/companies/news/198408/imugene-signs-exclusive-world-wide-licence-for-cancer-vaccine-198408.html Thu, 07 Jun 2018 01:29:00 +1000 https://www.proactiveinvestors.com.au/companies/news/198408/imugene-signs-exclusive-world-wide-licence-for-cancer-vaccine-198408.html Imugene pounces on material acquisition https://www.proactiveinvestors.com.au/companies/news/198223/imugene-pounces-on-material-acquisition-198223.html Tue, 05 Jun 2018 00:08:00 +1000 https://www.proactiveinvestors.com.au/companies/news/198223/imugene-pounces-on-material-acquisition-198223.html Imugene’s shares surge higher following early promise in gastric cancer trial https://www.proactiveinvestors.com.au/companies/news/191263/imugenes-shares-surge-higher-following-early-promise-in-gastric-cancer-trial-191263.html Wed, 07 Feb 2018 02:01:00 +1100 https://www.proactiveinvestors.com.au/companies/news/191263/imugenes-shares-surge-higher-following-early-promise-in-gastric-cancer-trial-191263.html Imugene targets cash injection for immuno-oncology clinical testing https://www.proactiveinvestors.com.au/companies/news/187538/imugene-targets-cash-injection-for-immuno-oncology-clinical-testing-187538.html Mon, 20 Nov 2017 22:56:00 +1100 https://www.proactiveinvestors.com.au/companies/news/187538/imugene-targets-cash-injection-for-immuno-oncology-clinical-testing-187538.html Imugene granted Canadian patent for proprietary cancer vaccine https://www.proactiveinvestors.com.au/companies/news/181254/imugene-granted-canadian-patent-for-proprietary-cancer-vaccine-181254.html Fri, 21 Jul 2017 03:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/181254/imugene-granted-canadian-patent-for-proprietary-cancer-vaccine-181254.html Imugene raises $3M from option plan to advance immunotherapy studies https://www.proactiveinvestors.com.au/companies/news/176058/imugene-raises-3m-from-option-plan-to-advance-immunotherapy-studies-176058.html Thu, 06 Apr 2017 04:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/176058/imugene-raises-3m-from-option-plan-to-advance-immunotherapy-studies-176058.html Imugene Ltd appoints Leslie Chong to chief executive officer https://www.proactiveinvestors.com.au/companies/news/169291/imugene-ltd-appoints-leslie-chong-to-chief-executive-officer-169291.html Mon, 21 Nov 2016 21:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/169291/imugene-ltd-appoints-leslie-chong-to-chief-executive-officer-169291.html Imugene gets ready to raise https://www.proactiveinvestors.com.au/companies/news/167599/imugene-gets-ready-to-raise-167599.html Tue, 18 Oct 2016 21:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/167599/imugene-gets-ready-to-raise-167599.html Imugene Ltd gets site approval for gastric cancer study in Thailand https://www.proactiveinvestors.com.au/companies/news/165297/imugene-ltd-gets-site-approval-for-gastric-cancer-study-in-thailand-70586.html Mon, 22 Aug 2016 03:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/165297/imugene-ltd-gets-site-approval-for-gastric-cancer-study-in-thailand-70586.html Imugene Ltd to start gastric cancer treatment studies in Taiwan https://www.proactiveinvestors.com.au/companies/news/165296/imugene-ltd-to-start-gastric-cancer-treatment-studies-in-taiwan-70375.html Thu, 11 Aug 2016 02:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/165296/imugene-ltd-to-start-gastric-cancer-treatment-studies-in-taiwan-70375.html Imugene Ltd gains approval for gastric cancer study in Hong Kong https://www.proactiveinvestors.com.au/companies/news/156526/imugene-ltd-gains-approval-for-gastric-cancer-study-in-hong-kong-69717.html Mon, 11 Jul 2016 02:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/156526/imugene-ltd-gains-approval-for-gastric-cancer-study-in-hong-kong-69717.html Imugene initiates pan-Asia trial of gastric cancer treatment therapy https://www.proactiveinvestors.com.au/companies/news/156525/imugene-initiates-pan-asia-trial-of-gastric-cancer-treatment-therapy-68218.html Thu, 21 Apr 2016 06:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/156525/imugene-initiates-pan-asia-trial-of-gastric-cancer-treatment-therapy-68218.html Imugene rings in changes as gastric cancer trial preparation picks up pace https://www.proactiveinvestors.com.au/companies/news/156524/imugene-rings-in-changes-as-gastric-cancer-trial-preparation-picks-up-pace--66430.html Tue, 05 Jan 2016 01:42:00 +1100 https://www.proactiveinvestors.com.au/companies/news/156524/imugene-rings-in-changes-as-gastric-cancer-trial-preparation-picks-up-pace--66430.html Imugene cashes up ahead of hotly anticipated cancer treatment trials https://www.proactiveinvestors.com.au/companies/news/156523/imugene-cashes-up-ahead-of-hotly-anticipated-cancer-treatment-trials-65323.html Wed, 28 Oct 2015 04:53:00 +1100 https://www.proactiveinvestors.com.au/companies/news/156523/imugene-cashes-up-ahead-of-hotly-anticipated-cancer-treatment-trials-65323.html Imugene raises $3M to start gastric cancer clinical trial https://www.proactiveinvestors.com.au/companies/news/156521/imugene-raises-3m-to-start-gastric-cancer-clinical-trial-64415.html Tue, 08 Sep 2015 02:17:00 +1000 https://www.proactiveinvestors.com.au/companies/news/156521/imugene-raises-3m-to-start-gastric-cancer-clinical-trial-64415.html Imugene Limited on road to raising https://www.proactiveinvestors.com.au/companies/news/156520/imugene-limited-on-road-to-raising-64387.html Mon, 07 Sep 2015 06:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/156520/imugene-limited-on-road-to-raising-64387.html Imugene Limited appoints Leslie Chong as chief operating officer https://www.proactiveinvestors.com.au/companies/news/156519/imugene-limited-appoints-leslie-chong-as-chief-operating-officer-64236.html Thu, 27 Aug 2015 06:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/156519/imugene-limited-appoints-leslie-chong-as-chief-operating-officer-64236.html Imugene on track to start gastric cancer clinical trial in 2H 2015 https://www.proactiveinvestors.com.au/companies/news/156518/imugene-on-track-to-start-gastric-cancer-clinical-trial-in-2h-2015-63226.html Tue, 30 Jun 2015 22:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/156518/imugene-on-track-to-start-gastric-cancer-clinical-trial-in-2h-2015-63226.html Imugene issuing 5 million options to non-executive director Dr Axel Hoos https://www.proactiveinvestors.com.au/companies/news/156517/imugene-issuing-5-million-options-to-non-executive-director-dr-axel-hoos-63187.html Mon, 29 Jun 2015 07:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/156517/imugene-issuing-5-million-options-to-non-executive-director-dr-axel-hoos-63187.html Imugene Limited appoints Dr Ursula Wiedermann as chief scientific officer https://www.proactiveinvestors.com.au/companies/news/156516/imugene-limited-appoints-dr-ursula-wiedermann-as-chief-scientific-officer-62767.html Fri, 05 Jun 2015 03:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/156516/imugene-limited-appoints-dr-ursula-wiedermann-as-chief-scientific-officer-62767.html Imugene: research shows Her-Vaxx tumour inhibition promise https://www.proactiveinvestors.com.au/companies/news/107296/imugene-research-shows-her-vaxx-tumour-inhibition-promise-107296.html Fri, 22 May 2015 08:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/107296/imugene-research-shows-her-vaxx-tumour-inhibition-promise-107296.html Imugene files for new cancer vaccine patent https://www.proactiveinvestors.com.au/companies/news/68262/imugene-files-for-new-cancer-vaccine-patent-79532.html Tue, 21 Apr 2015 12:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/68262/imugene-files-for-new-cancer-vaccine-patent-79532.html Imugene Limited sees large increase in cancer fighting antibodies https://www.proactiveinvestors.com.au/companies/news/68213/imugene-limited-sees-large-increase-in-cancer-fighting-antibodies--79477.html Mon, 20 Apr 2015 09:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/68213/imugene-limited-sees-large-increase-in-cancer-fighting-antibodies--79477.html Cancer Vaccines: Immunotherapy’s New Wave https://www.proactiveinvestors.com.au/companies/news/68161/cancer-vaccines-immunotherapys-new-wave-79420.html Fri, 17 Apr 2015 05:10:00 +1000 https://www.proactiveinvestors.com.au/companies/news/68161/cancer-vaccines-immunotherapys-new-wave-79420.html Imugene shares rise on heavy volume https://www.proactiveinvestors.com.au/companies/news/66436/imugene-shares-rise-on-heavy-volume-77534.html Mon, 23 Feb 2015 09:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/66436/imugene-shares-rise-on-heavy-volume-77534.html Imugene banks research and development tax refund https://www.proactiveinvestors.com.au/companies/news/66344/imugene-banks-research-and-development-tax-refund-77434.html Wed, 18 Feb 2015 10:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/66344/imugene-banks-research-and-development-tax-refund-77434.html Imugene progressing cancer vaccine towards clinical studies https://www.proactiveinvestors.com.au/companies/news/66177/imugene-progressing-cancer-vaccine-towards-clinical-studies-77253.html Thu, 12 Feb 2015 14:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/66177/imugene-progressing-cancer-vaccine-towards-clinical-studies-77253.html Imugene Limited Melbourne/Sydney Investor Luncheon Presentation https://www.proactiveinvestors.com.au/companies/news/305741/imugene-limited-melbournesydney-investor-luncheon-presentation-483.html Tue, 10 Feb 2015 02:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/305741/imugene-limited-melbournesydney-investor-luncheon-presentation-483.html Imugene therapy targets cancer at Melbourne, Sydney Luncheons https://www.proactiveinvestors.com.au/companies/news/156515/imugene-therapy-targets-cancer-at-melbourne-sydney-luncheons-60547.html Fri, 06 Feb 2015 00:11:00 +1100 https://www.proactiveinvestors.com.au/companies/news/156515/imugene-therapy-targets-cancer-at-melbourne-sydney-luncheons-60547.html Imugene Limited appoints Charles Walker as managing director https://www.proactiveinvestors.com.au/companies/news/65847/imugene-limited-appoints-charles-walker-as-managing-director-76878.html Mon, 02 Feb 2015 14:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/65847/imugene-limited-appoints-charles-walker-as-managing-director-76878.html Imugene hits milestones on the road to Her-Vaxx 2015 clinical program https://www.proactiveinvestors.com.au/companies/news/156514/imugene-hits-milestones-on-the-road-to-her-vaxx-2015-clinical-program-59822.html Tue, 30 Dec 2014 01:58:00 +1100 https://www.proactiveinvestors.com.au/companies/news/156514/imugene-hits-milestones-on-the-road-to-her-vaxx-2015-clinical-program-59822.html Imugene director increases indirect interest through share placement https://www.proactiveinvestors.com.au/companies/news/64624/imugene-director-increases-indirect-interest-through-share-placement-75485.html Tue, 16 Dec 2014 12:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/64624/imugene-director-increases-indirect-interest-through-share-placement-75485.html Imugene Limited CEO Charles Walker speaks about using Immuno-oncology in the fight against cancer https://www.proactiveinvestors.com.au/companies/news/305740/imugene-limited-ceo-charles-walker-speaks-about-using-immuno-oncology-in-the-fight-against-cancer-471.html Wed, 10 Dec 2014 01:27:00 +1100 https://www.proactiveinvestors.com.au/companies/news/305740/imugene-limited-ceo-charles-walker-speaks-about-using-immuno-oncology-in-the-fight-against-cancer-471.html Imugene meets heavy demand in capital raising for HER-Vaxx https://www.proactiveinvestors.com.au/companies/news/64390/imugene-meets-heavy-demand-in-capital-raising-for-her-vaxx-75222.html Tue, 09 Dec 2014 10:33:00 +1100 https://www.proactiveinvestors.com.au/companies/news/64390/imugene-meets-heavy-demand-in-capital-raising-for-her-vaxx-75222.html Imugene's HER-Vaxx demonstrates high level of activity in preclinical testing https://www.proactiveinvestors.com.au/companies/news/64118/imugenes-her-vaxx-demonstrates-high-level-of-activity-in-preclinical-testing-74923.html Mon, 01 Dec 2014 12:04:00 +1100 https://www.proactiveinvestors.com.au/companies/news/64118/imugenes-her-vaxx-demonstrates-high-level-of-activity-in-preclinical-testing-74923.html Imugene Limited extends share purchase plan https://www.proactiveinvestors.com.au/companies/news/64112/imugene-limited-extends-share-purchase-plan-74917.html Mon, 01 Dec 2014 08:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/64112/imugene-limited-extends-share-purchase-plan-74917.html Imugene to divest Linguet™, focus on HER-Vaxx for gastric cancer https://www.proactiveinvestors.com.au/companies/news/64074/imugene-to-divest-linguet-focus-on-her-vaxx-for-gastric-cancer-74869.html Fri, 28 Nov 2014 09:37:00 +1100 https://www.proactiveinvestors.com.au/companies/news/64074/imugene-to-divest-linguet-focus-on-her-vaxx-for-gastric-cancer-74869.html Imugene Limited extends share purchase plan https://www.proactiveinvestors.com.au/companies/news/64034/imugene-limited-extends-share-purchase-plan-74826.html Thu, 27 Nov 2014 21:39:00 +1100 https://www.proactiveinvestors.com.au/companies/news/64034/imugene-limited-extends-share-purchase-plan-74826.html Imugene is undervalued v ASX, global peers in Immuno-Oncology https://www.proactiveinvestors.com.au/companies/news/64036/imugene-is-undervalued-v-asx-global-peers-in-immuno-oncology-74828.html Thu, 27 Nov 2014 08:02:00 +1100 https://www.proactiveinvestors.com.au/companies/news/64036/imugene-is-undervalued-v-asx-global-peers-in-immuno-oncology-74828.html Imugene Limited looks to boost funds for cancer research https://www.proactiveinvestors.com.au/companies/news/156513/imugene-limited-looks-to-boost-funds-for-cancer-research-58635.html Mon, 03 Nov 2014 00:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/156513/imugene-limited-looks-to-boost-funds-for-cancer-research-58635.html Imugene to be granted patent for cancer vaccine in Israel https://www.proactiveinvestors.com.au/companies/news/156512/imugene-to-be-granted-patent-for-cancer-vaccine-in-israel-53848.html Mon, 24 Mar 2014 01:46:00 +1100 https://www.proactiveinvestors.com.au/companies/news/156512/imugene-to-be-granted-patent-for-cancer-vaccine-in-israel-53848.html Imugene secures intellectual property over a proposed cancer vaccine https://www.proactiveinvestors.com.au/companies/news/156511/imugene-secures-intellectual-property-over-a-proposed-cancer-vaccine-51301.html Thu, 19 Dec 2013 05:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/156511/imugene-secures-intellectual-property-over-a-proposed-cancer-vaccine-51301.html Imugene Limited to disclose acquisition, capital raising https://www.proactiveinvestors.com.au/companies/news/156510/imugene-limited-to-disclose-acquisition-capital-raising-49296.html Mon, 21 Oct 2013 02:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/156510/imugene-limited-to-disclose-acquisition-capital-raising-49296.html Imugene to be granted European patent for bone loss prevention drug delivery technology https://www.proactiveinvestors.com.au/companies/news/156509/imugene-to-be-granted-european-patent-for-bone-loss-prevention-drug-delivery-technology-48553.html Fri, 27 Sep 2013 05:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/156509/imugene-to-be-granted-european-patent-for-bone-loss-prevention-drug-delivery-technology-48553.html Imugene looks to melt a vitamin D in your mouth https://www.proactiveinvestors.com.au/companies/news/156508/imugene-looks-to-melt-a-vitamin-d-in-your-mouth-46505.html Thu, 08 Aug 2013 00:20:00 +1000 https://www.proactiveinvestors.com.au/companies/news/156508/imugene-looks-to-melt-a-vitamin-d-in-your-mouth-46505.html Imugene granted Chinese patent for drug delivery system, launches share purchase plan https://www.proactiveinvestors.com.au/companies/news/156507/imugene-granted-chinese-patent-for-drug-delivery-system-launches-share-purchase-plan-42620.html Mon, 29 Apr 2013 23:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/156507/imugene-granted-chinese-patent-for-drug-delivery-system-launches-share-purchase-plan-42620.html Imugene focuses on developing pharmaceutical products for early revenues https://www.proactiveinvestors.com.au/companies/news/156506/imugene-focuses-on-developing-pharmaceutical-products-for-early-revenues-33646.html Thu, 20 Sep 2012 03:50:00 +1000 https://www.proactiveinvestors.com.au/companies/news/156506/imugene-focuses-on-developing-pharmaceutical-products-for-early-revenues-33646.html Imugene readies to update market on potential acquisition, in ASX trading halt https://www.proactiveinvestors.com.au/companies/news/156505/imugene-readies-to-update-market-on-potential-acquisition-in-asx-trading-halt--28319.html Tue, 01 May 2012 04:40:00 +1000 https://www.proactiveinvestors.com.au/companies/news/156505/imugene-readies-to-update-market-on-potential-acquisition-in-asx-trading-halt--28319.html Imugene steps back from poultry vaccines https://www.proactiveinvestors.com.au/companies/news/156504/imugene-steps-back-from-poultry-vaccines-24036.html Wed, 11 Jan 2012 05:55:00 +1100 https://www.proactiveinvestors.com.au/companies/news/156504/imugene-steps-back-from-poultry-vaccines-24036.html Imugene exits trading halt with Global License Agreement announcement https://www.proactiveinvestors.com.au/companies/news/156503/imugene-exits-trading-halt-with-global-license-agreement-announcement-19227.html Fri, 02 Sep 2011 04:48:00 +1000 https://www.proactiveinvestors.com.au/companies/news/156503/imugene-exits-trading-halt-with-global-license-agreement-announcement-19227.html Imugene in pre-open pending 'strategic alliance' announcement https://www.proactiveinvestors.com.au/companies/news/156502/imugene-in-pre-open-pending-strategic-alliance-announcement-19159.html Thu, 01 Sep 2011 00:15:00 +1000 https://www.proactiveinvestors.com.au/companies/news/156502/imugene-in-pre-open-pending-strategic-alliance-announcement-19159.html Imugene completes laboratory development of Swine Influenza Vaccines https://www.proactiveinvestors.com.au/companies/news/156501/imugene-completes-laboratory-development-of-swine-influenza-vaccines-2086.html Mon, 27 Jul 2009 04:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/156501/imugene-completes-laboratory-development-of-swine-influenza-vaccines-2086.html